Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Sarepta Therapeutics Cash Flow from Investing Activities 2010-2024 | SRPT

Sarepta Therapeutics annual/quarterly cash flow from investing activities history and growth rate from 2010 to 2024. Cash flow from investing activities can be defined as the total change in cash resulting from a companies investments
  • Sarepta Therapeutics cash flow from investing activities for the quarter ending March 31, 2024 was $0.219B, a 1651.49% increase year-over-year.
  • Sarepta Therapeutics cash flow from investing activities for the twelve months ending March 31, 2024 was $0.061B, a 101.92% decline year-over-year.
  • Sarepta Therapeutics annual cash flow from investing activities for 2023 was $-0.166B, a 84.16% decline from 2022.
  • Sarepta Therapeutics annual cash flow from investing activities for 2022 was $-1.047B, a 311.32% decline from 2021.
  • Sarepta Therapeutics annual cash flow from investing activities for 2021 was $0.495B, a 507.01% decline from 2020.
  
Sarepta Therapeutics Annual Cash Flow Investing
(Millions of US $)
2023 $-166
2022 $-1,047
2021 $495
2020 $-122
2019 $287
2018 $-370
2017 $-179
2016 $-90
2015 $8
2014 $-159
2013 $-12
2012 $-1
2011 $-2
2010 $-2
2009 $-2
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $10.712B $1.243B
Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company that focuses on the discovery and development of RNA-based therapeutics targeting rare and infectious diseases. It concentrates on the development of exon-skipping drug candidates targeting Duchenne muscular dystrophy (DMD), a rare genetic disorder affecting children. The company received accelerated approval for Exondys 51, Amondys 45 (casimersen) and Vyondys 53 (golodirsen). Exondys 51 is Sarepta's first PMO-based technology to be granted accelerated approval by the FDA. The company is conducting a confirmatory study on the clinical benefits of these drugs for gaining continued approval. The rest of its exon-skipping DMD pipeline includes a PPMO-based, exon 51 skipping candidate, SRP-5051. Sarepta is also developing gene therapies for treating DMD, Limb-girdle muscular dystrophy and central nervous system disorders including Mucopolysaccharidosis type IIIA and Pompe Disease.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $161.032B 16.11
Vertex Pharmaceuticals (VRTX) United States $115.319B 29.67
Regeneron Pharmaceuticals (REGN) United States $107.228B 26.22
GSK (GSK) United Kingdom $91.685B 10.95
CSL (CSLLY) Australia $90.281B 0.00
Bristol Myers Squibb (BMY) United States $82.077B 38.56
Gilead Sciences (GILD) United States $79.660B 15.87
Moderna (MRNA) United States $58.712B 0.00
Biogen (BIIB) United States $31.846B 14.58
BioNTech SE (BNTX) Germany $22.370B 188.20
Argenex SE (ARGX) Netherlands $21.772B 0.00
Alnylam Pharmaceuticals (ALNY) United States $18.981B 0.00
Genmab (GMAB) Denmark $18.521B 21.71
Illumina (ILMN) United States $16.731B 119.35
BeiGene (BGNE) Cayman Islands $14.651B 0.00
BioMarin Pharmaceutical (BMRN) United States $14.133B 55.13
Incyte (INCY) United States $12.855B 19.88
Bio-Techne Corp (TECH) United States $12.511B 47.26
QIAGEN (QGEN) Netherlands $9.817B 20.97
Repligen (RGEN) United States $8.759B 114.42
Roivant Sciences (ROIV) United Kingdom $8.727B 0.00
Exact Sciences (EXAS) United States $8.677B 0.00
Bio-Rad Laboratories (BIO.B) United States $7.984B 26.11
Legend Biotech (LEGN) United States $7.598B 0.00
Vaxcyte (PCVX) United States $7.474B 0.00
Ascendis Pharma (ASND) Denmark $7.414B 0.00
Viking Therapeutics (VKTX) United States $7.207B 0.00
Insmed (INSM) United States $7.142B 0.00
Intra-Cellular Therapies (ITCI) United States $6.928B 0.00
Blueprint Medicines (BPMC) United States $6.409B 0.00
Exelixis (EXEL) United States $6.167B 31.78
Halozyme Therapeutics (HALO) United States $5.483B 15.22
Cytokinetics (CYTK) United States $5.055B 0.00
Apellis Pharmaceuticals (APLS) United States $4.923B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $4.657B 0.00
ImmunityBio (IBRX) United States $4.578B 0.00
Zealand Pharma (ZLDPF) Denmark $4.574B 0.00
Krystal Biotech (KRYS) United States $4.541B 0.00
Nuvalent (NUVL) United States $4.330B 0.00
Immunovant (IMVT) United States $4.129B 0.00
Alkermes (ALKS) Ireland $4.019B 15.73
Axsome Therapeutics (AXSM) United States $3.646B 0.00
Biohaven (BHVN) United States $3.350B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $3.337B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.270B 0.00
Merus (MRUS) Netherlands $3.220B 0.00
Guardant Health (GH) United States $3.201B 0.00
SpringWorks Therapeutics (SWTX) United States $3.135B 0.00
Xenon Pharmaceuticals (XENE) Canada $2.914B 0.00
IDEAYA Biosciences (IDYA) United States $2.841B 0.00
Amicus Therapeutics (FOLD) United States $2.838B 0.00
Apogee Therapeutics (APGE) United States $2.798B 0.00
MorphoSys AG (MOR) Germany $2.794B 0.00
Arcellx (ACLX) United States $2.745B 0.00
Iovance Biotherapeutics (IOVA) United States $2.714B 0.00
Denali Therapeutics (DNLI) United States $2.695B 0.00
Certara (CERT) United States $2.680B 61.70
MoonLake Immunotherapeutics (MLTX) Switzerland $2.664B 0.00
Avidity Biosciences (RNA) United States $2.517B 0.00
ACADIA Pharmaceuticals (ACAD) United States $2.493B 0.00
Twist Bioscience (TWST) United States $2.471B 0.00
Janux Therapeutics (JANX) United States $2.450B 0.00
Arvinas (ARVN) United States $2.412B 0.00
Celldex Therapeutics (CLDX) United States $2.332B 0.00
Vericel (VCEL) United States $2.331B 0.00
Immunocore Holdings (IMCR) United Kingdom $2.316B 0.00
Fortrea Holdings (FTRE) United States $2.253B 27.69
Rhythm Pharmaceuticals (RYTM) United States $2.208B 0.00
Deciphera Pharmaceuticals (DCPH) United States $2.206B 0.00
ADMA Biologics Inc (ADMA) United States $2.205B 86.46
Intellia Therapeutics (NTLA) United States $2.192B 0.00
Novavax (NVAX) United States $2.178B 0.00
CG Oncology (CGON) United States $2.161B 0.00
Myriad Genetics (MYGN) United States $2.111B 0.00
Kymera Therapeutics (KYMR) United States $2.057B 0.00
Vera Therapeutics (VERA) United States $2.031B 0.00
Bavarian Nordic (BVNRY) Denmark $1.996B 8.69
Beam Therapeutics (BEAM) United States $1.994B 0.00
Geron (GERN) United States $1.987B 0.00
Rocket Pharmaceuticals (RCKT) United States $1.901B 0.00
Zai Lab (ZLAB) China $1.831B 0.00
NeoGenomics (NEO) United States $1.805B 0.00
Inhibrx (INBX) United States $1.800B 0.00
Galapagos (GLPG) Belgium $1.792B 0.00
Keros Therapeutics (KROS) United States $1.759B 0.00
Protagonist Therapeutics (PTGX) United States $1.758B 12.29
Structure Therapeutics (GPCR) United States $1.729B 0.00
Sana Biotechnology (SANA) United States $1.728B 0.00
Syndax Pharmaceuticals (SNDX) United States $1.707B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.671B 12.74
Kura Oncology (KURA) United States $1.637B 0.00
Edgewise Therapeutics (EWTX) United States $1.603B 0.00
Ligand Pharmaceuticals (LGND) United States $1.548B 25.29
Morphic Holding (MORF) United States $1.542B 0.00
Neumora Therapeutics (NMRA) United States $1.517B 0.00
Dynavax Technologies (DVAX) United States $1.505B 191.67
Vir Biotechnology (VIR) United States $1.460B 0.00
Arcus Biosciences (RCUS) United States $1.425B 0.00
Ginkgo Bioworks Holdings (DNA) United States $1.382B 0.00
Belite Bio (BLTE) United States $1.357B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $1.351B 0.00
Akero Therapeutics (AKRO) United States $1.348B 0.00
Spyre Therapeutics (SYRE) United States $1.333B 0.00
Cullinan Therapeutics (CGEM) United States $1.327B 0.00
ANI Pharmaceuticals (ANIP) United States $1.326B 16.47
Tarsus Pharmaceuticals (TARS) United States $1.298B 0.00
MannKind (MNKD) United States $1.261B 154.33
AbCellera Biologics (ABCL) Canada $1.200B 0.00
Day One Biopharmaceuticals (DAWN) United States $1.189B 0.00
Mirum Pharmaceuticals (MIRM) United States $1.167B 0.00
MiMedx (MDXG) United States $1.109B 46.94
Prothena (PRTA) Ireland $1.073B 0.00
Autolus Therapeutics (AUTL) United Kingdom $1.069B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $1.034B 0.00
Arcutis Biotherapeutics (ARQT) United States $1.028B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $1.005B 0.00
Immatics (IMTX) Germany $0.988B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.983B 0.00
Mesoblast (MESO) Australia $0.973B 0.00
Liquidia Technologies (LQDA) United States $0.939B 0.00
Humacyte (HUMA) United States $0.892B 0.00
Immunome (IMNM) United States $0.877B 0.00
Gyre Therapeutics (GYRE) United States $0.868B 0.00
Abivax SA (ABVX) France $0.864B 0.00
Tyra Biosciences (TYRA) United States $0.863B 0.00
Disc Medicine (IRON) United States $0.857B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.842B 0.00
Scholar Rock Holding (SRRK) United States $0.824B 0.00
CureVac (CVAC) Germany $0.822B 0.00
89BIO (ETNB) United States $0.819B 0.00
Cogent Biosciences (COGT) United States $0.804B 0.00
PureTech Health (PRTC) United States $0.791B 0.00
Prime Medicine (PRME) United States $0.780B 0.00
Cytek Biosciences (CTKB) United States $0.778B 0.00
Viridian Therapeutics (VRDN) United States $0.778B 0.00
Pliant Therapeutics (PLRX) United States $0.777B 0.00
Praxis Precision Medicines (PRAX) United States $0.773B 0.00
Nurix Therapeutics (NRIX) United States $0.764B 0.00
WAVE Life Sciences (WVE) Singapore $0.752B 0.00
GH Research (GHRS) Ireland $0.746B 0.00
REGENXBIO (RGNX) United States $0.737B 0.00
Stoke Therapeutics (STOK) United States $0.733B 0.00
Tango Therapeutics (TNGX) United States $0.732B 0.00
Nuvation Bio (NUVB) United States $0.732B 0.00
Longboard Pharmaceuticals (LBPH) United States $0.726B 0.00
CARGO Therapeutics (CRGX) United States $0.704B 0.00
Castle Biosciences (CSTL) United States $0.677B 0.00
ALX Oncology Holdings (ALXO) United States $0.654B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Dianthus Therapeutics (DNTH) United States $0.643B 0.00
AnaptysBio (ANAB) United States $0.638B 0.00
ArriVent BioPharma (AVBP) United States $0.635B 0.00
Arbutus Biopharma (ABUS) United States $0.632B 0.00
HilleVax (HLVX) United States $0.630B 0.00
Pharming Group (PHGUF) Netherlands $0.622B 0.00
ITeos Therapeutics (ITOS) United States $0.617B 0.00
Zymeworks (ZYME) United States $0.616B 0.00
Pharming Group (PHAR) Netherlands $0.609B 0.00
Mineralys Therapeutics (MLYS) United States $0.604B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.602B 0.00
Oric Pharmaceuticals (ORIC) United States $0.594B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.587B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.580B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.571B 0.00
Kyverna Therapeutics (KYTX) United States $0.570B 0.00
Third Harmonic Bio (THRD) United States $0.559B 0.00
EnGene Holdings (ENGN) United States $0.548B 0.00
Avid Bioservices (CDMO) United States $0.547B 0.00
IGM Biosciences (IGMS) United States $0.545B 0.00
Entrada Therapeutics (TRDA) United States $0.545B 25.62
Adaptive Biotechnologies (ADPT) United States $0.538B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.533B 0.00
Northwest Biotherapeutics (NWBO) United States $0.526B 0.00
Olema Pharmaceuticals (OLMA) United States $0.517B 0.00
Cabaletta Bio (CABA) United States $0.515B 0.00
Travere Therapeutics (TVTX) United States $0.515B 0.00
MaxCyte (MXCT) United States $0.505B 0.00
Astria Therapeutics (ATXS) United States $0.497B 0.00
Alector (ALEC) United States $0.494B 0.00
Absci (ABSI) United States $0.483B 0.00
Oculis Holding AG (OCS) Switzerland $0.482B 0.00
Fulcrum Therapeutics (FULC) United States $0.481B 0.00
Applied Therapeutics (APLT) United States $0.474B 0.00
Celcuity (CELC) United States $0.473B 0.00
PepGen (PEPG) United States $0.470B 0.00
MEREO BIOPHARMA (MREO) United Kingdom $0.470B 0.00
Aerovate Therapeutics (AVTE) United States $0.463B 0.00
TScan Therapeutics (TCRX) United States $0.462B 0.00
Annexon (ANNX) United States $0.458B 0.00
Ocugen (OCGN) United States $0.440B 0.00
Editas Medicine (EDIT) United States $0.438B 0.00
Erasca (ERAS) United States $0.437B 0.00
Voyager Therapeutics (VYGR) United States $0.436B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.424B 0.00
Biomea Fusion (BMEA) United States $0.419B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.416B 0.00
Allogene Therapeutics (ALLO) United States $0.415B 0.00
Neurogene (NGNE) United States $0.412B 0.00
Terns Pharmaceuticals (TERN) United States $0.409B 0.00
Fate Therapeutics (FATE) United States $0.403B 0.00
ACELYRIN, INC (SLRN) United States $0.401B 0.00
FibroBiologics (FBLG) United States $0.392B 0.00
AC Immune (ACIU) Switzerland $0.383B 0.00
Contineum Therapeutics (CTNM) United States $0.378B 0.00
Adlai Nortye (ANL) Cayman Islands $0.372B 0.00
C4 Therapeutics (CCCC) United States $0.369B 0.00
Anika Therapeutics (ANIK) United States $0.367B 309.50
Ventyx Biosciences (VTYX) United States $0.362B 0.00
Jasper Therapeutics (JSPR) United States $0.361B 0.00
Aura Biosciences (AURA) United States $0.359B 0.00
Shattuck Labs (STTK) United States $0.349B 0.00
Skye Bioscience (SKYE) United States $0.345B 0.00
Amarin (AMRN) Ireland $0.345B 0.00
Precigen (PGEN) United States $0.345B 0.00
Anavex Life Sciences (AVXL) United States $0.344B 0.00
Sutro Biopharma (STRO) United States $0.342B 0.00
MeiraGTx Holdings (MGTX) United States $0.331B 0.00
Alto Neuroscience (ANRO) United States $0.330B 0.00
Tenaya Therapeutics (TNYA) United States $0.325B 0.00
Nautilus Biotechnology (NAUT) United States $0.323B 0.00
Agenus (AGEN) United States $0.320B 0.00
Nkarta (NKTX) United States $0.320B 0.00
Urogen Pharma (URGN) United States $0.319B 0.00
Replimune (REPL) United States $0.318B 0.00
Q32 Bio (QTTB) United States $0.313B 0.00
Atea Pharmaceuticals (AVIR) United States $0.304B 0.00
Kamada (KMDA) Israel $0.301B 22.78
XOMA (XOMA) United States $0.297B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.296B 0.00
CorMedix Inc (CRMD) United States $0.295B 0.00
Mersana Therapeutics (MRSN) United States $0.294B 0.00
Solid Biosciences (SLDB) United States $0.291B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.290B 0.00
Revance Therapeutics (RVNC) United States $0.279B 0.00
Poseida Therapeutics (PSTX) United States $0.277B 0.00
Inozyme Pharma (INZY) United States $0.272B 0.00
Caribou Biosciences (CRBU) United States $0.270B 0.00
Inovio Pharmaceuticals (INO) United States $0.269B 0.00
23andMe Holding (ME) United States $0.263B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.257B 0.00
Candel Therapeutics (CADL) United States $0.254B 0.00
Prima BioMed (IMMP) Australia $0.251B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.249B 0.00
Emergent Biosolutions (EBS) United States $0.247B 0.00
XBiotech (XBIT) United States $0.238B 0.00
Design Therapeutics (DSGN) United States $0.238B 0.00
Innate Pharma S.A (IPHA) France $0.235B 0.00
Rani Therapeutics Holdings (RANI) United States $0.232B 0.00
GENFIT S.A (GNFT) France $0.231B 0.00
UniQure (QURE) Netherlands $0.229B 0.00
Zura Bio (ZURA) United States $0.229B 0.00
Codexis (CDXS) United States $0.222B 0.00
2seventy Bio (TSVT) United States $0.220B 0.00
Compugen (CGEN) Israel $0.218B 0.00
Renovaro (RENB) United States $0.217B 0.00
Ovid Therapeutics (OVID) United States $0.216B 0.00
Coherus BioSciences (CHRS) United States $0.216B 0.00
Werewolf Therapeutics (HOWL) United States $0.216B 0.00
Boundless Bio (BOLD) United States $0.214B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.211B 0.00
Compass Therapeutics (CMPX) United States $0.211B 0.00
Invivyd (IVVD) United States $0.210B 0.00
Elevation Oncology (ELEV) United States $0.209B 0.00
ChromaDex (CDXC) United States $0.209B 0.00
INmune Bio (INMB) United States $0.201B 0.00
Scilex Holding (SCLX) United States $0.196B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.195B 0.00
Puma Biotechnology (PBYI) United States $0.194B 12.18
Inventiva S.A (IVA) France $0.186B 0.00
Oncobiologics (OTLK) United States $0.186B 0.00
Opthea (OPT) Australia $0.183B 0.00
Trevi Therapeutics (TRVI) United States $0.180B 0.00
G1 Therapeutics (GTHX) United States $0.178B 0.00
Greenwich LifeSciences (GLSI) United States $0.170B 0.00
Lifecore Biomedical (LFCR) United States $0.169B 0.00
Abeona Therapeutics (ABEO) United States $0.169B 0.00
Alimera Sciences (ALIM) United States $0.163B 0.00
Adverum Biotechnologies (ADVM) United States $0.159B 0.00
X4 Pharmaceuticals (XFOR) United States $0.158B 0.00
Kodiak Sciences (KOD) United States $0.158B 0.00
Sagimet Biosciences (SGMT) United States $0.157B 0.00
Cellectis S.A (CLLS) France $0.155B 0.00
Cartesian Therapeutics (RNAC) United States $0.151B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.150B 0.00
Rezolute (RZLT) United States $0.148B 0.00
Cardiff Oncology (CRDF) United States $0.145B 0.00
Rapt Therapeutics (RAPT) United States $0.142B 0.00
TELA Bio (TELA) United States $0.142B 0.00
Seres Therapeutics (MCRB) United States $0.141B 0.00
I-Mab (IMAB) China $0.141B 0.00
CytomX Therapeutics (CTMX) United States $0.139B 8.95
Repare Therapeutics (RPTX) Canada $0.138B 0.00
Molecular Partners AG (MOLN) Switzerland $0.138B 0.00
ScPharmaceuticals (SCPH) United States $0.137B 0.00
Gossamer Bio (GOSS) United States $0.134B 0.00
Syros Pharmaceuticals (SYRS) United States $0.134B 0.00
Sangamo Therapeutics (SGMO) United States $0.129B 0.00
Adicet Bio (ACET) United States $0.128B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.126B 0.00
Vigil Neuroscience (VIGL) United States $0.124B 0.00
BioStem Technologies (BSEM) $0.124B 0.00
ATyr Pharma (LIFE) United States $0.124B 0.00
Allakos (ALLK) United States $0.123B 0.00
Seer (SEER) United States $0.122B 0.00
Nuvectis Pharma (NVCT) United States $0.121B 0.00
Omega Therapeutics (OMGA) United States $0.116B 0.00
DBV Technologies S.A (DBVT) France $0.115B 0.00
PDS Biotechnology (PDSB) United States $0.114B 0.00
Akoya Biosciences (AKYA) United States $0.114B 0.00
Coya Therapeutics (COYA) United States $0.114B 0.00
Immunic (IMUX) United States $0.113B 0.00
CervoMed (CRVO) United States $0.112B 0.00
Adagene (ADAG) China $0.112B 0.00
VistaGen Therapeutics (VTGN) United States $0.110B 0.00
DiaMedica Therapeutics (DMAC) United States $0.108B 0.00
BioHarvest Sciences (CNVCF) Canada $0.106B 0.00
BeyondSpring (BYSI) United States $0.105B 0.00
Clearside Biomedical (CLSD) United States $0.104B 0.00
Vor Biopharma (VOR) $0.103B 0.00
Bluebird Bio (BLUE) United States $0.103B 0.00
Verastem (VSTM) United States $0.102B 0.00
Athira Pharma (ATHA) United States $0.098B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.095B 0.00
Connect Biopharma Holdings (CNTB) United States $0.094B 0.00
Eton Pharmaceuticals (ETON) United States $0.092B 90.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.088B 0.00
Cognition Therapeutics (CGTX) United States $0.088B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.088B 0.00
Precision BioSciences (DTIL) United States $0.088B 0.00
Gritstone Bio (GRTS) United States $0.087B 0.00
InflaRx (IFRX) Germany $0.086B 0.00
IO Biotech (IOBT) Denmark $0.085B 0.00
Oncolytics Biotech (ONCY) Canada $0.083B 0.00
Elicio Therapeutics (ELTX) United States $0.083B 0.00
BioAtla (BCAB) United States $0.081B 0.00
Elutia (ELUT) United States $0.080B 0.00
Benitec Biopharma (BNTC) United States $0.080B 0.00
Provectus Biopharmaceuticals (PVCT) United States $0.080B 0.00
Galena Biopharma (SLS) United States $0.080B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.079B 0.00
Cue Biopharma (CUE) United States $0.079B 0.00
Spero Therapeutics (SPRO) United States $0.078B 2.82
HOOKIPA Pharma (HOOK) United States $0.077B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.077B 0.00
Genelux (GNLX) United States $0.075B 0.00
Annovis Bio (ANVS) United States $0.074B 0.00
VTv Therapeutics (VTVT) United States $0.074B 0.00
Atara Biotherapeutics (ATRA) United States $0.074B 0.00
Aileron Therapeutics (ALRN) United States $0.074B 0.00
Passage Bio (PASG) United States $0.073B 0.00
Alpha Teknova (TKNO) United States $0.072B 0.00
Instil Bio (TIL) United States $0.071B 0.00
BioXcel Therapeutics (BTAI) United States $0.070B 0.00
Bionano Genomics (BNGO) United States $0.069B 0.00
Intensity Therapeutics (INTS) United States $0.068B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.068B 0.00
Lantern Pharma (LTRN) United States $0.066B 0.00
AVROBIO (AVRO) United States $0.066B 0.00
Curis (CRIS) United States $0.066B 0.00
Rallybio (RLYB) United States $0.065B 0.00
Celularity (CELU) United States $0.065B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.065B 0.00
Entera Bio (ENTX) Israel $0.065B 0.00
MediciNova (MNOV) United States $0.065B 0.00
Ikena Oncology (IKNA) United States $0.064B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.064B 0.00
Checkpoint Therapeutics (CKPT) United States $0.064B 0.00
AN2 Therapeutics (ANTX) United States $0.063B 0.00
Turnstone Biologics (TSBX) United States $0.063B 0.00
Affimed (AFMD) Germany $0.062B 0.00
Genenta Science S.p.A (GNTA) Italy $0.062B 0.00
Immix Biopharma (IMMX) United States $0.061B 0.00
Enzo Biochem (ENZ) United States $0.060B 0.00
Leap Therapeutics (LPTX) United States $0.058B 0.00
Theratechnologies (THTX) Canada $0.058B 0.00
Dyadic (DYAI) United States $0.057B 0.00
CalciMedica (CALC) United States $0.056B 0.00
LENZ Therapeutics (LENZ) United States $0.056B 0.00
Earth Science Tech (ETST) United States $0.056B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.054B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.054B 0.00
Cidara Therapeutics (CDTX) United States $0.054B 0.00
Carmell (CTCX) United States $0.053B 0.00
Kezar Life Sciences (KZR) United States $0.052B 0.00
Ocean Biomedical (OCEA) United States $0.052B 0.00
ARCA Biopharma (ABIO) United States $0.052B 0.00
Equillium (EQ) United States $0.051B 0.00
Aligos Therapeutics (ALGS) United States $0.048B 0.00
IN8bio (INAB) United States $0.046B 0.00
Aadi Bioscience (AADI) United States $0.046B 0.00
Kronos Bio (KRON) United States $0.045B 0.00
Lexaria Bioscience (LEXX) Canada $0.044B 0.00
Clene (CLNN) United States $0.044B 0.00
Ocuphire Pharma (OCUP) United States $0.043B 0.00
Beyond Air (XAIR) United States $0.043B 0.00
Immuneering (IMRX) United States $0.043B 0.00
NextCure (NXTC) United States $0.042B 0.00
HCW Biologics (HCWB) United States $0.042B 0.00
Dare Bioscience (DARE) United States $0.041B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.040B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.038B 0.00
OKYO Pharma (OKYO) $0.038B 0.00
Eyenovia (EYEN) United States $0.037B 0.00
NKGen Biotech (NKGN) United States $0.037B 0.00
Cara Therapeutics (CARA) United States $0.037B 0.00
Cyclo Therapeutics (CYTH) United States $0.037B 0.00
Quince Therapeutics (QNCX) United States $0.036B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.036B 0.00
Estrella Immunopharma (ESLA) United States $0.036B 0.00
Pluri (PLUR) Israel $0.036B 0.00
Fortress Biotech (FBIO) United States $0.035B 0.00
Xilio Therapeutics (XLO) United States $0.034B 0.00
MiNK Therapeutics (INKT) United States $0.033B 0.00
Evogene (EVGN) Israel $0.032B 0.00
RenovoRx (RNXT) United States $0.030B 0.00
Promis Neurosciences (PMN) Canada $0.030B 0.00
BioAffinity Technologies (BIAF) United States $0.030B 0.00
Bolt Biotherapeutics (BOLT) United States $0.029B 0.00
Aprea Therapeutics (APRE) United States $0.028B 0.00
Spruce Biosciences (SPRB) United States $0.028B 0.00
UNITY Biotechnology (UBX) United States $0.027B 0.00
Femasys (FEMY) United States $0.027B 0.00
SAB Biotherapeutics (SABS) United States $0.025B 0.00
Lisata Therapeutics (LSTA) United States $0.024B 0.00
Forte Biosciences (FBRX) United States $0.024B 0.00
Apollomics (APLM) United States $0.023B 0.00
Cocrystal Pharma (COCP) United States $0.023B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.023B 0.00
BRIACELL THERAP (BCTX) Canada $0.022B 0.00
Biora Therapeutics (BIOR) United States $0.022B 0.00
Sensei Biotherapeutics (SNSE) United States $0.021B 0.00
Evaxion Biotech (EVAX) Denmark $0.021B 0.00
NeuroBo Pharmaceuticals (NRBO) United States $0.020B 0.00
Purple Biotech (PPBT) Israel $0.020B 0.00
Vincerx Pharma (VINC) United States $0.019B 0.00
Synlogic (SYBX) United States $0.019B 0.00
Lumos Pharma (LUMO) United States $0.019B 0.00
Aptose Biosciences (APTO) Canada $0.019B 0.00
VBI Vaccines (VBIV) United States $0.018B 0.00
KALA BIO (KALA) United States $0.018B 0.00
Aytu BioPharma (AYTU) United States $0.018B 0.00
Galecto (GLTO) Denmark $0.017B 0.00
Talis Biomedical (TLIS) United States $0.016B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.016B 0.00
Orgenesis (ORGS) United States $0.016B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.015B 0.00
Senti Biosciences (SNTI) United States $0.015B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.015B 0.00
Imunon (IMNN) United States $0.014B 0.00
Edesa Biotech (EDSA) Canada $0.014B 0.00
IMMURON (IMRN) Australia $0.013B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.013B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.013B 0.00
Semper Paratus Acquisition (TVGN) United States $0.013B 0.00
Elevai Labs (ELAB) United States $0.012B 0.00
Galera Therapeutics (GRTX) United States $0.011B 0.00
Monopar Therapeutics (MNPR) United States $0.011B 0.00
Moleculin Biotech (MBRX) United States $0.011B 0.00
Kintara Therapeutics (KTRA) United States $0.010B 0.00
Eterna Therapeutics (ERNA) United States $0.010B 0.00
AEterna Zentaris (AEZS) Canada $0.010B 0.00
ABVC BioPharma (ABVC) United States $0.010B 0.00
Chemomab Therapeutics (CMMB) Israel $0.010B 0.00
Organovo Holdings (ONVO) United States $0.010B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.010B 0.00
NuCana (NCNA) United Kingdom $0.010B 0.00
BioCardia (BCDA) United States $0.010B 0.00
Genetic Technologies (GENE) Australia $0.009B 0.00
Prana Biotechnology (ATHE) Australia $0.009B 0.00
Biorestorative Therapies (BRTX) United States $0.009B 0.00
EFFECTOR Therapeutics (EFTR) United States $0.008B 0.00
Bionomics (BNOX) Australia $0.008B 0.00
Vaccinex (VCNX) United States $0.008B 0.00
Cyclerion Therapeutics (CYCN) United States $0.007B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.007B 0.00
AquaBounty Technologies (AQB) United States $0.007B 0.00
Psyence Biomedical (PBM) United States $0.007B 0.00
Trevena (TRVN) United States $0.007B 0.00
Atrinsic (PTIX) United States $0.007B 0.00
Tenax Therapeutics (TENX) United States $0.007B 0.00
TFF Pharmaceuticals (TFFP) United States $0.007B 0.00
Longeveron (LGVN) United States $0.007B 0.00
Pulmatrix (PULM) United States $0.007B 0.00
Pasithea Therapeutics (KTTA) United States $0.007B 0.00
Cadrenal Therapeutics (CVKD) United States $0.006B 0.00
Entero Therapeutics (ENTO) United States $0.006B 0.00
Hepion Pharmaceuticals (HEPA) United States $0.006B 0.00
Enveric Biosciences (ENVB) United States $0.006B 0.00
Telesis Bio (TBIO) United States $0.006B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.006B 0.00
Titan Pharmaceuticals (TTNP) United States $0.006B 0.00
Kineta (KA) United States $0.006B 0.00
Soligenix (SNGX) United States $0.006B 0.00
Hoth Therapeutics (HOTH) United States $0.006B 0.00
Synaptogenix (SNPX) United States $0.006B 0.00
Bright Minds Biosciences (DRUG) United States $0.006B 0.00
Silo Pharma (SILO) United States $0.005B 0.00
Biofrontera (BFRI) United States $0.005B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.005B 0.00
Adial Pharmaceuticals (ADIL) United States $0.005B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.005B 0.00
GT Biopharma (GTBP) United States $0.005B 0.00
Portage Biotech (PRTG) $0.005B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.005B 0.00
ThermoGenesis Holdings (THMO) United States $0.005B 0.00
Virios Therapeutics (VIRI) United States $0.005B 0.00
Novogen (KZIA) Australia $0.004B 0.00
Palisade Bio (PALI) United States $0.004B 0.00
GENPREX (GNPX) United States $0.004B 0.00
Artelo Biosciences (ARTL) United States $0.004B 0.00
Ensysce Biosciences (ENSC) United States $0.004B 0.00
Cingulate (CING) United States $0.004B 0.00
NexImmune (NEXI) United States $0.004B 0.00
TRACON Pharmaceuticals (TCON) United States $0.004B 0.43
Alzamend Neuro (ALZN) United States $0.004B 0.00
GeoVax Labs (GOVX) United States $0.004B 0.00
Onconetix (ONCO) United States $0.004B 0.00
TC BioPharm (Holdings) (TCBP) United Kingdom $0.004B 0.00
Tharimmune (THAR) United States $0.004B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.004B 0.00
Invo BioScience (INVO) United States $0.003B 0.00
Avalon GloboCare (ALBT) United States $0.003B 0.00
Exicure (XCUR) United States $0.003B 0.17
Seelos Therapeutics (SEEL) United States $0.003B 0.00
Aptevo Therapeutics (APVO) United States $0.003B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.003B 0.00
Revelation Biosciences (REVB) United States $0.003B 0.00
CNS Pharmaceuticals (CNSP) United States $0.002B 0.00
Mustang Bio (MBIO) United States $0.002B 0.00
Windtree Therapeutics (WINT) United States $0.002B 0.00
Notable Labs (NTBL) United States $0.002B 0.00
Bone Biologics (BBLG) United States $0.002B 0.00
180 Life Sciences (ATNF) United States $0.002B 0.00
Dermata Therapeutics (DRMA) United States $0.001B 0.00
NeuBase Therapeutics (NBSE) United States $0.001B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.001B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.001B 0.00
Allarity Therapeutics (ALLR) United States $0.001B 0.00
GRI Bio (GRI) United States $0.001B 0.00
Virpax Pharmaceuticals (VRPX) United States $0.001B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.001B 0.00
Sunshine Biopharma (SBFM) United States $0.001B 0.00
Aceragen (ACGN) United States $0.000B 0.00
Alvotech (ALVO) $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
Mainz Biomed (MYNZ) Germany $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pharvaris (PHVS) Netherlands $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00